Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 167

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease

Open access
Kálmán, J., Juhász, A., Laird, G., Dickens, P., Járdánházy, T., Rimanóczy, A., Boncz, I., Parry-Jones, W. L. I., Janka, Z. · 2009 · Acta Neurologica Scandinavica

Abstract

INTRODUCTION: Inflammatory processes are suspected in the pathomechanism of Alzheimer's dementia (AD) but the serum and cerebrospinal fluid (CSF) levels of inflammatory cytokines are not yet determined in the different forms of the disorder. SUBJECTS AND METHODS: Interleukin-6 (IL-6) levels were examined in the sera and CSF of patients with mild-moderate and severe stage of late onset sporadic type of AD and in the sera of demented Down syndrome (DS) probands with similar stages of AD and compared with data of age-matched healthy controls. RESULTS: Normal serum IL-6 levels were found in the mild-moderate stage, but significantly increased levels were found in the severe stage of both dementia groups. The CSF concentrations remained within the normal range in all groups. Positive correlations between the serum IL-6 levels and age and the severity of the disease were present. CONCLUSION: These findings suggest a disease stage dependent general activation of the immune system both in sporadic AD and in DS with AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1600-0404.1997.tb00275.x

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 25

  1. Levy, 1990, Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type, Science, 248, 1124, 10.1126/science.2111584 · DOI · Paper page
  2. Wisniewski, 1985, Discrepancy between Alzheimer-type neuropathology and dementia in persons with Down's syndrome, Ann NY Acad Sci, 477, 247, 10.1111/j.1749-6632.1986.tb40344.x · DOI
  3. Cork, 1990, Neuropathology of Down syndrome and Alzheimer disease, Am J Med Genet, 7, 282
  4. Berkenbosch, 1993, Cytokines and inflammatory proteins in Alzheimer's disease, Res Immunol, 143, 657, 10.1016/0923-2494(92)80052-M · DOI
  5. Licastro, 1995, Acute phase reactant alfa-1-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer disease, Alzheimer Dis Assoc Disord, 2, 112, 10.1097/00002093-199509020-00009 · DOI
  6. Akiyama, 1991, Immunohistochemical localization of vitronectin, its receptor and beta-3 integrin in Alzheimer brain tissue, J Neuro-immunol, 32, 19
  7. Satoh, 1988, Induction of neuronal differentation in PC12 cells by B-cell stimulatory factor 2/ interleukin 6, Mol Cell Biol, 8, 3546, 10.1128/MCB.8.8.3546 · DOI · Paper page
  8. Campbell, 1993, Neurologic disease induced in transgenic mice by cerebral over-expression of interleukin-6, Proc Natl Acad Sci USA, 90, 10061, 10.1073/pnas.90.21.10061 · DOI · Paper page
  9. Bo, 1995, Reciprocal control of inflammatory cytokines, IL-1, and IL-6, and beta-amyloid production in cultures, Neurosci Lett, 188, 70, 10.1016/0304-3940(95)11384-9 · DOI · Paper page
  10. Brugg, 1995, Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain, Proc Natl Acad Sci USA, 92, 3032, 10.1073/pnas.92.7.3032 · DOI · Paper page
  11. Vries, 1996, The influence of cytokines on the integrity of the blood-brain barrier in vitro, J Neuroimmunol, 64, 37, 10.1016/0165-5728(95)00148-4 · DOI · Paper page
  12. Schapiro, 1987, Decline in cerebral glucose utilisation and cognitive function with aging in Down's syndrome, J Neurol Neurosurg Psychiatry, 50, 766, 10.1136/jnnp.50.6.766 · DOI
  13. McKhann, 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group, Neurology, 34, 939, 10.1212/WNL.34.7.939 · DOI · Paper page
  14. American Psychiatric Association (APA), 1987, Diagnostic and Statistical Manual of Mental Disorders
  15. Folstein, 1975, Mini-mental state. A practical method for grading the cognitive state of patients for the clinician, J Psychiat Res, 12, 189, 10.1016/0022-3956(75)90026-6 · DOI · Paper page
  16. Duijn, 1990, Serum levels of interleukin-6 are not elevated in patients with Alzheimer's disease, Neurosci Lett, 108, 350, 10.1016/0304-3940(90)90666-W · DOI
  17. Yamada, 1995, Decreased interleukin-6 level in the cerebrospinal fluid of patients with Alzheimer's-type of dementia, Neurosci Lett, 186, 219, 10.1016/0304-3940(95)11318-Q · DOI
  18. Huberman, 1994, Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage, J Neuroimmunol, 52, 147, 10.1016/0165-5728(94)90108-2 · DOI
  19. Vandenabeele, 1991, IS amyloidogenesis during Alzheimer's disease due to an IL-1/IL-6-mediated “acute phase response” in the brain, Immunol Today, 217, 217, 10.1016/0167-5699(91)90032-O · DOI · Paper page
  20. Abraham, 1992, The role of acute-phase proteins alfa-l-antichymotrypsin in brain dysfunction and injury, Res Immunol, 143, 631, 10.1016/0923-2494(92)80047-O · DOI
  21. Erschler, 1993, Interleukin-6: a cytokine for gerontologist, J Am Geratr Soc, 41, 176, 10.1111/j.1532-5415.1993.tb02054.x · DOI · Paper page
  22. Pirtilla, 1994, Alfa-1-antichymotrypsin and IL-1 beta are not increased in CSF or serum in Alzheimer's disease, Neurobiol Aging, 15, 313, 10.1016/0197-4580(94)90026-4 · DOI
  23. Lawlor, 1996, Acute phase reactants in Alzheimer's disease, Biol Psychiatry, 39, 1051, 10.1016/0006-3223(95)00426-2 · DOI
  24. McRae, 1992, Immune responses in brains of Alzheimer's and Parkinson's disease patients: hypothesis and reality, Rev Neurosci, 3, 79, 10.1515/REVNEURO.1992.3.2.79 · DOI
  25. Perlmutter, 1990, Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review, Brain Res Bull, 24, 677, 10.1016/0361-9230(90)90007-M · DOI · Paper page

Cited by

See all 167

Metadata

Authors
Kálmán, J., Juhász, A., Laird, G., Dickens, P., Járdánházy, T., Rimanóczy, A., Boncz, I., Parry-Jones, W. L. I., & Janka, Z.
Venue
Acta Neurologica Scandinavica
Published
2009-01-29
Volume
96
Issue
4
Pages
236-240
ISSN
  • 0001-6314 (ISSN-L)
  • 1600-0404
OpenAlex
W2106182781
Cited by
167
References
9
FWCI
4.72
Type
journal article
Language
en
Open access
bronze
Licence
doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 2406 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease. https://app.cochat.ai/papers/10.1111/j.1600-0404.1997.tb00275.x
The paper
Kálmán, J., Juhász, A., Laird, G., Dickens, P., Járdánházy, T., Rimanóczy, A., Boncz, I., Parry-Jones, W. L. I., & Janka, Z. (2009). Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease. Acta Neurologica Scandinavica. https://doi.org/10.1111/j.1600-0404.1997.tb00275.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.